Skip to main content
. 2022 Sep 15;36(10):e22514. doi: 10.1096/fj.202200765R

TABLE 2.

Human AML cell lines used in this study

Cell line Source Mutations
OCI‐AML2 peripheral blood of a 65‐year‐old male with acute myeloid leukemia DNMT3A R635W (MLL‐MLLT4; MLL‐AF6) gene fusion
MOLM‐14 peripheral blood of a 20‐year‐old male with acute myeloid leukemia FLT3‐ITD (MLL‐MLLT3; MLL‐AF9) fusion
HL‐60 Peripheral blood of the 36‐year‐old female with acute promyelocytic leukemia N‐RAS Q61L, amplified c‐MYC
MV4‐11 Blasts of a 10‐year‐old male with biphenotypic B‐myelomonocytic leukemia (AML FAB M5) FLT3‐ITD, MLL‐AFF1 gene fusion